The methanolic extract of Myrsine seguinii yielded the novel anti-in‰ammatory compound, myrsinoic acid E (1), whose structure was elucidated to be 3,5-digeranyl-4-hydroxy benzoic acid. We synthesized 1-and its 3,5-diprenyl (2) and 3,5-difarnesyl analogues (3). Compounds 1-3 suppressed 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced in‰ammation of mouse ears by 59%, 14%, and 69% at a dose of 1.4 mmol.
Skin tumor promoters such as 12-O-tetradecanoylphorbol-13-acetate (TPA) induce edema on the skin with cell proliferation. 1, 2) Inhibitors of TPA-induced edema can be expected to suppress various physiological responses involving cell proliferation as well as in‰ammation. In a search for new types of antiin‰ammatory compounds, we found that the methanolic extract of Myrsine seguinii showed potent antiin‰ammatory activity. We have already reported the isolation and identiˆcation of four novel related compounds, myrsinoic acid A (4), 3) B, C and F. 4) In our continuing search for other anti-in‰amma-tory compounds from this plant, we isolated the novel terpeno-benzoic acid, myrsinoic acid E (1). However, we could not evaluate its anti-in‰ammato-ry activity because of its small amount. This prompted us to synthesize compound 1, as well as several analogues for further anti-in‰ammatory activity studies.
The methanolic extract of M. seguinii yielded myrsinoic acid E (1). The HR-EIMS analysis of this compound gave the molecular formula of C27H38O3 (found 410.2836) with nine unsaturations. The IR spectrum of 1 showed the presence of hydroxyl (3435 cm -1 ) and carboxyl (1683 cm -1 and 3200-2400 cm -1 ) groups. The 1 H-NMR and 13 C-NMR spectra of 1 showed close similarity with those of myrsinoic acid A (4). 3) In the 1 H-NMR spectrum, the only diŠerences were the presence in 1 of an oleˆnic methine triplet (H-6?, -6!) at d 5.08 (t, J＝6.7 Hz, 2H) and a symmetrical three-methyl singlet at 1.76, 1.68, and 1.60 (H-9?, -9!, -8?, -8!, -10?, -10!). These data indicate that compound 1 possessed two symmetric geranyl group at the 3, 5 position of 4-hydroxy benzoic acid. The 13 C-NMR spectrum of 1 was in complete accordance with the proposed structure.
The synthesis of compound 1 and its analogues 2 and 3 is shown in Scheme 1. 4-Iodophenol (5) was used as a starting material. The introduction of a 3,5-digeranyl group was performed by using Hori's procedure to give 6.
5) Pd-catalyzed carbonylation 6) aŠorded ester 9 in a 91z yield. Finally, hydrolysis of the methyl ester gave 1 in an 88z yield. The spectral data for synthetic 1 are in good accordance with those of natural 1. To examine the importance of the C-3 and C-5 side chain length on the anti-in‰amma-tory activity, we designed target molecule 2 with a prenyl group and 3 with a farnesyl group. The synthesis of 2 and 3 was performed as just described. The anti-in‰ammatory activities of compounds 1-4, and 4-hydroxybenzoic acid are summarized in Table 1 . Compounds 1, 3 and 4 showed strong antiin‰ammatory activity, while compound 2 and 4-hydroxybenzoic acid exhibited low activity. The long terpene moieties of terpeno-benzoic acid-type compounds seem to have been essential for the antiin‰ammatory activity.
Experimental
Instruments. The following instruments were used: a Bruker DR 500 FT-NMR spectrometer for 1 H-and 13 C-NMR spectra, a Jeol JMS 700 mass spectrometer for mass spectra, and a Jasco FT W IR-480 Plus for IR spectra.
Anti-in‰ammatory test. Mouse in‰ammatory tests were conducted by Gshwendt's method. 7) TPA was In parentheses: A sample (1.4 mmol) was applied on one mouse ear and, after 30 min, TPA (0.5 mg) was applied to both ears of the mouse. The edema was evaluated after 7 hr, the inhibitory eŠect being expressed as the percentage ratio of the edema. Five mice were used for each experiment. *At a dose of 500 mg (3.6 mmol).
purchased from Sigma Chemical Co. This experiment complied with the regulations concerning animal experimentation and the care of experimental animals of the Faculty of Agriculture at Shinshu University.
Isolation of compound 1. Fresh leaves and twigs of M. seguinii (12 kg) were extracted with methanol, and the extract was concentrated in vacuo. The aqueous solution was successively partitioned with hexane W water and ethyl acetate W water. Strong activity was found in the hexane-soluble portion (69 g), which was chromatographed in a silica gel column with hexane W ethyl acetate by 10z stepwise elution. The 20z ethyl acetate W hexane eluate (13.8 g) was chromatographed on ODS with gradient elution from 70z methanol W water to methanol. The active fraction was further puriˆed by HPLC (95z methanol W water) to give compound 1 (1.6 mg). HREIMS m W z Dialkylation of 4-Iodophenols. 3,5-Dialkyl-4-iodophenols were prepared according to the reported procedure.
5)
(2?E,2!E)-4-Iodo-2-(3?,7?-dimethylocta-2?,6?-dienyl)-6-(3!,7!-dimethylocta-2!,6!-dienyl)phenol (6 
4-Iodo-2-(3?-methyl-2?-butenyl)-6-(3!-methyl-2!-butenyl)phenol (7).
1 H-NMR data were identiˆed with those reported. Carbonylation of 2,6-dialkylated 4-iodophenols. To a solution of 2,6-dialkylated 4-iodophenol (0.5 mmol) in 1 ml of N, N-dimethylformamide (DMF) were successively added NEt3 (0.14 ml, 1 mmol), MeOH (64 mg, 2.0 mmol), and Cl2Pd(PPh3)2 (0.025 mmol, 17.6 mg). The mixture was charged with CO (1 atm), heated to 609 C, and stirred for 6 h. The usual work up gave a pure methyl ester after column chromatography (hexane W ethyl acetate＝8:1). Hydrolysis of methyl ester. 4-Hydroxy-3,5-dialkylated benzoic acids were prepared according to the reported procedure apart from using NaOH.
3) (2?E,2!E)-4-hydroxy-3-(3?,7?-dimethylocta-2?,6?-dienyl)-5-(3!,7!-dimethylocta-2!,6!-dienyl)benzoic acid (1). IR, 1 H-NMR, 13 C-NMR and HREIMS were identiˆed with those of myrsinoic acid E (1).
4-Hydroxy-3-(3?-methyl-2?-butenyl)-5-(3!-methyl-2!-butenyl)benzoic acid (2) . IR (ˆlm) nmax cm 
